Corcept Therapeutics Incorporated (CORT) Debt/EBITDA US GAAP (year values) |
|||||||||
2020 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | -3.70 | -3.64 | -2.69 | -3.87 | -3.40 | -2.58 | |||
Changes by years, y/y, % | +35% | -2% | -26% | +44% | -12% | +8.0% |
Corcept Therapeutics Incorporated. Debt/EBITDA
Corcept Therapeutics Incorporated. Debt/EBITDA, changes, %
Corcept Therapeutics Incorporated (CORT) Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
Debt/EBITDA | -3.59 | -3.39 | -3.33 | -3.63 | -2.58 | -2.58 | ||
Changes by years, y/y, % | +18% | -11% | -27% | +1% | -28% | |||
Changes by quarters, q/q, % | -1% | -6% | -2% | +9% | -29% |